US20050191395A1 - Hangover remedy and alcohol abatement composition - Google Patents
Hangover remedy and alcohol abatement composition Download PDFInfo
- Publication number
- US20050191395A1 US20050191395A1 US11/065,652 US6565205A US2005191395A1 US 20050191395 A1 US20050191395 A1 US 20050191395A1 US 6565205 A US6565205 A US 6565205A US 2005191395 A1 US2005191395 A1 US 2005191395A1
- Authority
- US
- United States
- Prior art keywords
- mixture
- approximately
- ions
- intoxication
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 162
- 239000000203 mixture Substances 0.000 title claims abstract description 139
- 206010019133 Hangover Diseases 0.000 title abstract description 13
- 235000019441 ethanol Nutrition 0.000 claims abstract description 93
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 53
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 26
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims abstract description 17
- 235000011130 ammonium sulphate Nutrition 0.000 claims abstract description 17
- 150000001413 amino acids Chemical class 0.000 claims abstract description 11
- 239000000796 flavoring agent Substances 0.000 claims abstract description 11
- 235000013373 food additive Nutrition 0.000 claims abstract description 11
- 239000002778 food additive Substances 0.000 claims abstract description 11
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 11
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 11
- 239000003765 sweetening agent Substances 0.000 claims abstract description 11
- 230000004060 metabolic process Effects 0.000 claims abstract description 9
- 238000006243 chemical reaction Methods 0.000 claims abstract description 7
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 24
- 150000001455 metallic ions Chemical class 0.000 claims description 22
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 16
- 230000008569 process Effects 0.000 claims description 14
- 241000282414 Homo sapiens Species 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 12
- 239000012153 distilled water Substances 0.000 claims description 11
- -1 silver ions Chemical class 0.000 claims description 11
- 239000003381 stabilizer Substances 0.000 claims description 11
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 claims description 10
- 239000004471 Glycine Substances 0.000 claims description 9
- 235000013405 beer Nutrition 0.000 claims description 8
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 235000014101 wine Nutrition 0.000 claims description 8
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 7
- 235000013905 glycine and its sodium salt Nutrition 0.000 claims description 7
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 6
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 6
- 235000010323 ascorbic acid Nutrition 0.000 claims description 6
- 239000011668 ascorbic acid Substances 0.000 claims description 6
- 229960005070 ascorbic acid Drugs 0.000 claims description 6
- 229910001431 copper ion Inorganic materials 0.000 claims description 6
- 235000008397 ginger Nutrition 0.000 claims description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 6
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 6
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 claims description 6
- 229910000367 silver sulfate Inorganic materials 0.000 claims description 6
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 6
- 239000004299 sodium benzoate Substances 0.000 claims description 6
- 235000010234 sodium benzoate Nutrition 0.000 claims description 6
- 239000011726 vitamin B6 Substances 0.000 claims description 6
- 239000000811 xylitol Substances 0.000 claims description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical group OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 6
- 235000010447 xylitol Nutrition 0.000 claims description 6
- 229960002675 xylitol Drugs 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- 241000234314 Zingiber Species 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 claims description 5
- HIAAPJWEVOPQRI-DFWYDOINSA-L copper;(2s)-2-aminopentanedioate Chemical compound [Cu+2].[O-]C(=O)[C@@H](N)CCC([O-])=O HIAAPJWEVOPQRI-DFWYDOINSA-L 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 235000013918 magnesium diglutamate Nutrition 0.000 claims description 5
- 229940063886 magnesium glutamate Drugs 0.000 claims description 5
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 5
- 239000004300 potassium benzoate Substances 0.000 claims description 5
- 235000010235 potassium benzoate Nutrition 0.000 claims description 5
- 229940103091 potassium benzoate Drugs 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 229910052709 silver Inorganic materials 0.000 claims description 5
- 239000004332 silver Substances 0.000 claims description 5
- 229910001923 silver oxide Inorganic materials 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- 239000011787 zinc oxide Substances 0.000 claims description 5
- GAMIYQSIKAOVTG-UHFFFAOYSA-L zinc;2-aminopentanedioate Chemical compound [Zn+2].[O-]C(=O)C(N)CCC([O-])=O GAMIYQSIKAOVTG-UHFFFAOYSA-L 0.000 claims description 5
- 241000207199 Citrus Species 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 4
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 4
- 229960004106 citric acid Drugs 0.000 claims description 4
- 235000015165 citric acid Nutrition 0.000 claims description 4
- 235000020971 citrus fruits Nutrition 0.000 claims description 4
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 4
- 229960003885 sodium benzoate Drugs 0.000 claims description 4
- 238000007865 diluting Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 230000002673 intoxicating effect Effects 0.000 claims description 2
- MYUGVHJLXONYNC-QHTZZOMLSA-J magnesium;(2s)-2-aminopentanedioate Chemical compound [Mg+2].[O-]C(=O)[C@@H](N)CCC([O-])=O.[O-]C(=O)[C@@H](N)CCC([O-])=O MYUGVHJLXONYNC-QHTZZOMLSA-J 0.000 claims 2
- 239000000463 material Substances 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 230000002378 acidificating effect Effects 0.000 abstract description 4
- 206010019233 Headaches Diseases 0.000 abstract description 2
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 2
- 206010028813 Nausea Diseases 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract description 2
- 206010013781 dry mouth Diseases 0.000 abstract description 2
- 231100000869 headache Toxicity 0.000 abstract description 2
- 230000009610 hypersensitivity Effects 0.000 abstract description 2
- 230000008693 nausea Effects 0.000 abstract description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 description 27
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 20
- 210000004185 liver Anatomy 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 235000013334 alcoholic beverage Nutrition 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- 244000144977 poultry Species 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 244000304337 Cuminum cyminum Species 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000004599 antimicrobial Substances 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 3
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 3
- 206010001605 Alcohol poisoning Diseases 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000001332 colony forming effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- MYUGVHJLXONYNC-QHTZZOMLSA-L magnesium;(2s)-2-amino-5-hydroxy-5-oxopentanoate Chemical compound [Mg+2].[O-]C(=O)[C@@H](N)CCC(O)=O.[O-]C(=O)[C@@H](N)CCC(O)=O MYUGVHJLXONYNC-QHTZZOMLSA-L 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 208000007848 Alcoholism Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 201000007930 alcohol dependence Diseases 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000012864 cross contamination Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000021472 generally recognized as safe Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 231100000566 intoxication Toxicity 0.000 description 2
- 230000035987 intoxication Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000015041 whisky Nutrition 0.000 description 2
- UPLPHRJJTCUQAY-WIRWPRASSA-N 2,3-thioepoxy madol Chemical compound C([C@@H]1CC2)[C@@H]3S[C@@H]3C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C)(O)[C@@]2(C)CC1 UPLPHRJJTCUQAY-WIRWPRASSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000863432 Shewanella putrefaciens Species 0.000 description 1
- 241001092391 Sorbus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- PLKYGPRDCKGEJH-UHFFFAOYSA-N azane;2-hydroxypropane-1,2,3-tricarboxylic acid;iron Chemical compound N.[Fe].OC(=O)CC(O)(C(O)=O)CC(O)=O PLKYGPRDCKGEJH-UHFFFAOYSA-N 0.000 description 1
- 210000004666 bacterial spore Anatomy 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 235000015123 black coffee Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 235000019788 craving Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000015092 herbal tea Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 235000008345 mountainash Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229940101270 nicotinamide adenine dinucleotide (nad) Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002898 organic sulfur compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003244 pro-oxidative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- KUNICNFETYAKKO-UHFFFAOYSA-N sulfuric acid;pentahydrate Chemical compound O.O.O.O.O.OS(O)(=O)=O KUNICNFETYAKKO-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 229910000385 transition metal sulfate Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/50—Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment
- C02F1/505—Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment by oligodynamic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/66—Treatment of water, waste water, or sewage by neutralisation; pH adjustment
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/02—Non-contaminated water, e.g. for industrial water supply
- C02F2103/026—Treating water for medical or cosmetic purposes
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/22—Nature of the water, waste water, sewage or sludge to be treated from the processing of animals, e.g. poultry, fish, or parts thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- This invention relates to an anti-intoxication composition for combating the side effects of an excessive consumption of alcohol, and in particular, a composition, method for making and using the composition to effectively change the harmful effects of alcohol metabolism in vivo.
- Alcohol specifically ethyl alcohol or ethanol, produced by fermenting the starch or sugar in various fruits and grains, has been a part of human civilization from the moment man figured out how to make it. Beverages produced by fermentation and distillation include beer, usually about 5% alcohol, wine, usually 12 to 15% alcohol, and hard liquor, which is approximately 45% alcohol or higher. No reliable statistics exist for worldwide liquor production and consumption because of unreported household production, wide variations in alcohol concentrations of various liquors and under reporting.
- Recent findings tout the benefits of a daily alcoholic drink for women or two drinks for men of wine, beer, or spirits for proven health benefits, and the more regular the pattern and amount consumed, the more positive properties.
- Alcohol in small to moderate amounts has the potential to elevate high density lipoprotein (HDL) cholesterol, which protects the cardiovascular system and decreases risk of heart attack.
- HDL high density lipoprotein
- This phenomenon was first observed in France, a country known for both a rich diet high in saturated fats and a low incidence of heart disease. A likely reason for this “French Paradox” is that their fat-laden meals are consumed with wine.
- a hangover including, but not limited to, a pounding headache, nausea, dry mouth, shaking hands, hypersensitivity to bright lights and sounds.
- acetaldehyde When alcohol enters the digestive tract, it encounters an enzyme called dehydrogenase that metabolizes it into acetaldehyde.
- dehydrogenase A close chemical relative of formaldehyde, which is used to embalm bodies, acetaldehyde is 30 times more toxic than alcohol.
- acetaldehyde When a moderate amount of alcohol is consumed, acetaldehyde is converted into a harmless compound called acetic acid. However, when an excess amount of alcohol is consumed, the nutrients required for the conversion to acetic acid are depleted, and acetaldehyde stays in the system and wreaks havoc on the body.
- Acetaldehyde is also a potent pro-oxidant that drains your body's stores of antioxidants, B vitamins, and other vital nutrients. The results are dehydration, plummeting blood sugar levels, nutrient deficiencies and cellular damage to vital organs, such as, the liver.
- U.S. Pat. No. 4,346,082 to Revici describes the use of inorganic sulfur compounds (i.e., ammonium sulfate solution with pH>5) for reducing or preventing alcohol intoxication.
- U.S. Pat. No. 4,565,689 to Revici describes organic sulfur compounds in treatments to control the cravings for alcohol.
- U.S. Pat. No. 4,582,705 to Primes describes a composition used to detoxify alcoholics which includes magnesium sulfate, copper ions, etc.
- Herbal and natural remedies for treating alcohol hangovers and remedies to increase alcohol degradation within the body include enzymes and taurine as disclosed by Fuchs et al. in U.S. Pat. No. 6,514,544; calcium compounds from seaweed by Auchincloss in U.S. Pat. No. 6,346,275; herbal teas extracted from leaves, stems, roots or alder and mountain ash trees by Nam in U.S. Pat. No. 5,968,520; herbal or vegetable extracts containing naturally occurring daidzin and diadzein by Duthinh in U.S. Pat. No. 5,547,671 and Capsicum pepper and bark or wood of the poplar tree by Fontaine et al. in U.S. Pat. No. 4,931,277.
- the plethora of hangover remedies and the broad range of anti-intoxication compositions are indicative of the need to find a reliable solution to the problem caused by excessive consumption of alcohol by human beings.
- the present invention provides an effective formulation to protect against damage to the body caused by excessive alcohol intake.
- the first objective of the present invention is to provide an alcohol hangover remedy.
- the second objective of the present invention is to provide an ingestible substance that facilitates metabolic conversion of alcohol to amino acids.
- the third objective of the present invention is to provide a composition of matter that ameliorates certain negative effects of excess alcohol consumption.
- the fourth objective of the present invention is to provide an easy to take dosage that changes bodily alcoholic content into a harmless, perhaps even beneficial, amino acid.
- the fifth objective of the present invention is to provide a composition of matter that reduces the strain on the human liver when metabolizing an excessive amount of alcohol.
- the sixth objective of the present invention is to increase the alcohol degradation capacity of an individual.
- a preferred anti-intoxication composition is made by combining sulfuric acid of approximately 94% purity to approximately 99.9% purity in a 1 to 2 volume ratio with distilled water and ammonium sulfate in a ratio of 2.77 pounds of ammonium sulfate per gallon of distilled water to provide a first mixture, then combining the first mixture in a pressurized vessel at a pressure that is above atmospheric pressure and heating the mixture at a temperature in a range between approximately 200 degrees Fahrenheit and approximately 1200 degrees Fahrenheit, for at least 30 minutes. The first mixture is then cooled and a stabilizer is added. The stabilizer is a portion of the first mixture and is 10 weight percent of the total weight of the first mixture. The first mixture and stabilizer form the second mixture.
- a compound containing metallic ions to is added to the second mixture to form a third mixture.
- the third mixture is diluted with water prior to adding sweeteners, flavoring agents and food additives to provide a composition that converts ethanol to amino-ethanoic acid, commonly known as glycine.
- the preferred metallic ions are copper ions, silver ions, zinc ions, magnesium ions and mixtures thereof; available from compounds, such as, but not limited to, copper sulfate, copper sulfate pentahydrate, copper glutamate, zinc oxide, zinc glutamate, magnesium glutamate, magnesium sulfate, silver oxide and silver sulfate.
- DC voltage is in a range from approximately 1 amp to approximately 100 amps, more preferably in a range from approximately 1 amp to approximately 5 amps.
- the sweetener in the anti-intoxication composition can be xylitol, sorbitol and mixtures thereof.
- the preferred flavoring agent is, but is not limited to, ginger and citrus essence.
- the ratio of water used to form a solution of the compound containing metallic ions to the total weight of the third mixture is in a range between approximately 2% to approximately 75% by weight.
- the preferred food additive is a food grade citric acid, ascorbic acid, sodium benzoate, potassium benzoate, vitamin B6 and mixtures thereof.
- the preferred method of making an anti-intoxication composition that is used to convert ethanol to an amino acid in the human body includes adding sulfuric acid of approximately 94 percent purity to a first container; heating distilled water in a ratio of twice the volume of the sulfuric acid in a separate container to at least 1400 F; mixing ammonium sulfate in the heated water in a ratio of 2.77 pounds per gallon of water to form a first mixture; simultaneously combining the mixture of sulfuric acid, heated distilled water, and ammonium sulfate (mixture I) in a separate pressurized vessel by injection; heating the pressurized mixture to a temperature in a range between approximately 200° F. and approximately 1200° F.
- a second mixture for approximately 30 minutes to form a second mixture; cooling mixture (II) and adding a stabilizer portion of the first mixture to the cooled mixture, wherein the stabilizer comprises approximately 10 weight percent of the total weight of the second mixture; adding a compound containing metallic ions to mixture II to form a third mixture having a stable suspension of metallic ions; diluting the third mixture with water; adding at least one of a sweetener, a flavoring agent and a food additive to form a refreshing liquid; and administering an effective amount of the refreshing liquid to counteract the intoxicating effects of alcohol consumption in a human being.
- the preferred metallic ions are copper ions, silver ions, zinc ions, magnesium ions and mixtures thereof available from compounds including, but not limited to, copper sulfate, copper sulfate pentahydrate, copper glutamate, zinc oxide, zinc glutamate, magnesium glutamate, magnesium sulfate, silver oxide and silver sulfate.
- the preferred sweetener is xylitol, sorbitol and mixtures thereof.
- the preferred flavoring agent is ginger and citrus essence.
- the ratio of water used to form a solution of the compound containing metallic ions to the total weight of the third mixture is in a range between approximately 2% to approximately 75% by weight.
- the preferred food additives are citric acid, ascorbic acid, sodium benzoate, potassium benzoate, vitamin B6 and mixtures thereof.
- the present invention provides an anti-intoxication composition
- an anti-intoxication composition comprising metallic salts, sulfuric acid, ammonium sulfate, a sweetener, flavoring agents, food additives and water wherein a refreshing liquid, paste, gel or capsule is formed that facilitates the metabolism of ethanol to an amino acid, namely, amino-ethanoic acid, commonly known as, glycine.
- the ethanol can be in a pure form or as found in wine, beer or hard liquor.
- FIG. 1 is a graph showing the effect of PHB0020 on pathogenic and spoilage bacterial isolates exposed for 2 minutes.
- FIG. 2 is a graph showing the logarithm of reductions in bacterial colony levels.
- FIG. 3 shows the range alcohol intoxication symptoms as defined by blood alcohol concentration (BAC).
- a pressurized vessel that includes a cooling jacket and no electrode attachments; however, the preferred pressurized vessel is fitted with two electrodes, a cathode and anode, to provide a direct current (DC) voltage one (1) foot above the bottom of the container.
- the electrodes are spaced approximately three (3) feet apart.
- the processing steps of the present invention comprise combining sulfuric acid with purity in a range from approximately 94% to approximately 99.9%, in a 1 to 2 volume ratio with distilled water and ammonium sulfate in a ratio of 2.77 pounds of ammonium sulfate per gallon of distilled water to provide mixture (I).
- the mixture (1) is combined in a pressurized vessel having preferably two strategically placed electrodes, a cathode and anode.
- a direct current (DC) voltage is applied to the mixture.
- the voltage is applied in a range from approximately one (1) amp to approximately 100 amps, preferably between approximately 1 amp and approximately 5 amps.
- the mixture is then heated under pressure in a range of from approximately 1 pound per square inch (psi) to approximately 15 psi above atmospheric pressure. Heating of the mixture is in a range of from approximately 200° Fahrenheit (F.) to approximately 1200° F., preferably from approximately 800° F. to approximately 900° F. for approximately 30 minutes.
- F. Fahrenheit
- a judicious selection of temperature, time and pressure is required and should be adjusted to maintain a safe chemical reaction.
- a stabilizer is added.
- the stabilizer is a portion of mixture (I) prior to heating in the pressure vessel.
- the quantity of stabilizer used is approximately 10 weight percent of the total weight of mixture (1).
- the resulting acidic composition is useful for destroying microorganisms, having a pH of negative 3 ( ⁇ 3).
- the inventive step of the present invention requires the addition of compounds containing metallic ions for the extensive antimicrobial properties discussed herein. The following physical and chemical properties are observed when undiluted.
- PHB0020 pHarlo Blue 0020
- PHB0020 an antimicrobial, anti-bacterial agent, which has a formulation that is generally recognized as safe (GRAS) by the US Food and Drug Administration.
- GRAS safe
- the composition is listed below: Ingredient Percentage Copper Sulfate 16.4 Pentahydrate Sulfuric Acid 9.9 (processing aid) Ammonium 2.2 sulfate Distilled water 71.5
- the ingredients form a concentrate, which is combined in small amounts of less than 0.10 milliliters (ml) with 1 gallon of water to make PHB00200.
- Example 1 Table I, FIG. 1 , and FIG. 2 provide greater detail on the use and effectiveness of PHB0020 as an antimicrobial agent.
- scalding tank In processing plants for poultry and animal products, it is customary to use various water treatment processes, such as a scalding tank, spray bath, final rinse and chill water tank.
- the scalding tank is used to dip poultry prior to the removal of feathers; other animals are dipped to remove the outer coating of fur or hair.
- the scalding process permits cross contamination and spread of pathogens. It is important for the safety of the human food supply to provide an additive that can be used in water treatments to inhibit the growth and spread of pathogens and deleterious bacteria.
- the ideal additive would not evaporate at boiling point temperatures, would not be destroyed by high temperatures and would not be bound by organic material, such as blood and feces and rendered useless.
- scalder water was collected from the overflow or entrance end of a commercial poultry scalder.
- the water is sterilized or autoclaved to eliminate all populations of bacteria and bacterial spores to avoid interference during the study.
- the autoclaved scalder water is evaluated chemically and compared to raw scalder water to ensure that the organic material demand in raw and autoclaved scalder water is similar.
- sets of test tubes are prepared by adding 9 milliliters (ml) of sterilized scalder water to sterile polystyrene test tubes.
- One set is prepared as controls by adding 9 ml of sterilized scalder water to tubes.
- One set is prepared by adding 9 ml of sterilized scalder water and PHB0020 (the disinfectant) until the pH of 2.2 is achieved.
- Each bacterium is exposed, one at a time, to the sterilized scalder water with PHB0020 sanitizer for approximately 2 minutes at approximately 130° F. (55° C.) to mimic scalding.
- one ml of the suspension was enumerated using the aerobic plate count method by pour plating and incubating at approximately 95° F. (35° C.) for 48 hours.
- Table I below records microbial growth results in a scalder water project wherein sterilized water was heated to scalding temperatures of in a range of from approximately 120° F. (49° C.) to approximately 140° F. (60° C.), preferably to a temperature of approximately 130° F. (55° C.).
- Various concentrations of PHB0020 are added in a range between approximately 0.4 parts per million (ppm) to approximately 0.8 ppm, preferably at approximately 0.6 ppm and colonies of pathogens, indicator bacteria and spoilage bacteria are exposed to the treated scalder water.
- the graph shows the effect of PHB0020 on pathogenic and spoilage bacteria identified in the table above.
- the graph is divided in two sections, on the left is the control showing the logarithm of colony forming units for each bacterium and on the right is the graph of colony forming units after each bacterium is exposed for 2 minutes to scalder water treated with PHB0020.
- the graph shows that Listeria, a gram-positive bacterium, is hard to kill and E coli, a very prolific bacterium, has the highest reduction after a 2 minute exposure.
- the graph shows the logarithm of the reduction of bacterial levels for each bacterium. In most cases the log of colony forming units is less than three, with the most prolific bacterium, E coli having a log of less than five.
- PHB0020 functions as an antimicrobial agent, disinfectant, or sanitizer and is extremely effective for eliminating populations of pathogenic, indicator and spoilage bacteria in commercial scalder water under industrial scalding conditions.
- PHB0020 is an effective means for controlling bacteria in scalder water and may be used for controlling cross-contamination during scalding. Disinfection of poultry scalder water is crucial because it is the first area within the plant in which birds are immersed in a common bath wherein bacteria can be transferred from bird to bird.
- PHB0020 as an antimicrobial agent additive and active ingredient in an alcohol hangover remedy is described in greater detail below.
- a mixture of the composition of the present invention having approximately 1.2 mg/l of PHB0020 was prepared at room temperature; using the formulation in Table II below. It is understood by persons skilled in the art that variations in the amount of each ingredient are within the scope of the present invention. Thus, a reasonable range of ingredients, within ⁇ 5% of the stated value, can be used to adjust taste and desired effectiveness.
- the PHB0020 ingredient is used in a range of 0.5 mg/l to 5.50 mg/l.
- the composition of the present invention is prepared by first mixing PHB0020 which contains metallic ions with deionized water and then adding in sequence the edible inorganic acids: citric acid and ascorbic acid; the alkali-metal benzoate compounds: sodium benzoate and potassium benzoate; ginger; xylitol; and Vitamin B6.
- the ingredients are mixed in the percentages given in Table II above.
- the mixture is thoroughly stirred until the metallic ions in the PHB0020 starting material are completely blended and uniformly suspended.
- the liquid mixture can be used as a refreshing drink or concentrated and used as a paste, gel, or capsule that is diluted by fluids in the stomach cavity.
- the metabolism of alcohol takes place in both the stomach cavity and in the liver.
- an alcoholic beverage When an alcoholic beverage is swallowed, it passes through the stomach into the small intestine where the ethanol is rapidly absorbed and distributed throughout the body.
- the ethanol enters body tissues in proportion to the body's water content. Therefore, more ethanol is found in the blood and the brain than in muscle or fat tissue.
- the ethanol is greatly diluted by body fluids. For example, a 1-ounce shot of 100-proof whiskey, which contains 0.5 fluid ounces of ethanol (approximately 15 milliliters (ml), is diluted 5000-fold in a 150 pound human, producing a 0.02% blood alcohol concentration (BAC).
- BAC blood alcohol concentration
- Ethanol is toxic, and the body begins to dispose of it immediately upon its consumption. Over 90% of it is processed by the liver.
- the alcohol dehydrogenase (ADH) enzyme converts ethanol into acetaldehyde, which is itself toxic. Acetaldehyde is then destroyed by the ADH enzyme, which converts acetaldehyde to acetate ions.
- ADH alcohol dehydrogenase
- acetaldehyde is then destroyed by the ADH enzyme, which converts acetaldehyde to acetate ions.
- NAD nicotinamide-adenine dinucleotide
- NADH must be recycled to NAD for the disposal of ethanol to continue. If the amount of ethanol consumed is not great, the recycling can keep up with the disposal of ethanol.
- Disposal of ethanol occurs in both the stomach and the liver. In the stomach, the acetate is broken down into water and carbon dioxide, both of which are secreted. In the liver, the acetate is converted to energy by way of the citric acid cycle and into fat through fatty acid synthesis.
- the composition of the present invention increases the disposal of alcohol in the stomach; thus, reducing the strain on the human liver when metabolizing an excessive amount of alcohol.
- the PHB0020 ingredient is preferably used in a range of approximately 0.5 mg/l to approximately 5.50 mg/l in the anti-intoxication composition of the present invention.
- Example 3 The recovered products in Example 3 are ethanol and amino-ethanoic acid, commonly known as, glycine, a non-essential amino acid.
- Glycine is one of the major inhibitory neurotransmitters in the brain. Glycine helps build up glycogen levels in the liver helps make DNA, skin proteins, collagen and phospholipids, which make cell membranes. Glycine also participates in the major energy producing biochemical reaction in the body. Thus, the conversion of alcohol to glycine has potentially significant health benefits.
- the novel composition of the present invention is effective in preventing intoxication and offsetting the toxic effects of alcohol on those occasions when there is liberal indulgence in alcoholic drinks, beyond just a one or two drink limit.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Organic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fodder In General (AREA)
Abstract
An anti-intoxication composition and method of making and using are provided for treating and preventing drinker's remorse and other toxic effects of excessive alcohol consumption by humans. The anti-intoxication composition is an acidic mixture containing sweeteners, flavoring agents, food additives and a processed mixture of metallic salts, sulfuric acid, ammonium sulfate and water. When the anti-intoxication composition is ingested, it promotes the beneficial metabolism of alcohol, primarily ethanol, in the body. The beneficial metabolism results in the conversion of alcohol to amino acids and eliminates the toxic reactions of a hangover, including, but not limited to, a pounding headache, nausea, dry mouth, shaking hands, hypersensitivity to bright lights and sounds.
Description
- This invention claims the benefit of priority from U. S. Provisional Application Ser. No. 60/547,991 filed Feb. 26, 2004.
- This invention relates to an anti-intoxication composition for combating the side effects of an excessive consumption of alcohol, and in particular, a composition, method for making and using the composition to effectively change the harmful effects of alcohol metabolism in vivo.
- Alcohol, specifically ethyl alcohol or ethanol, produced by fermenting the starch or sugar in various fruits and grains, has been a part of human civilization from the moment man figured out how to make it. Beverages produced by fermentation and distillation include beer, usually about 5% alcohol, wine, usually 12 to 15% alcohol, and hard liquor, which is approximately 45% alcohol or higher. No reliable statistics exist for worldwide liquor production and consumption because of unreported household production, wide variations in alcohol concentrations of various liquors and under reporting.
- Recent findings tout the benefits of a daily alcoholic drink for women or two drinks for men of wine, beer, or spirits for proven health benefits, and the more regular the pattern and amount consumed, the more positive properties.
- Alcohol in small to moderate amounts has the potential to elevate high density lipoprotein (HDL) cholesterol, which protects the cardiovascular system and decreases risk of heart attack. This phenomenon was first observed in France, a country known for both a rich diet high in saturated fats and a low incidence of heart disease. A likely reason for this “French Paradox” is that their fat-laden meals are consumed with wine.
- Alcohol plays a role in insulin sensitivity as well. Moderate intake can improve the ability of cells to respond to insulin, which is essential for diabetes prevention and control. Light drinking also enhances memory and concentration and some very early studies suggest it may play a role in thwarting Alzheimer's disease. Thus, there is concurrence that human consumption of alcohol sensibly and in moderation is associated with better health and longer life, the abuse of alcohol is associated with many undesirable health outcomes.
- The problem is that alcohol taken in large amounts becomes a toxin. And when there is regular over consumption of alcohol, all of the protective effects are destroyed and there is a higher risk for all kinds of health problems, including the most immediate one: a hangover, including, but not limited to, a pounding headache, nausea, dry mouth, shaking hands, hypersensitivity to bright lights and sounds.
- When alcohol enters the digestive tract, it encounters an enzyme called dehydrogenase that metabolizes it into acetaldehyde. A close chemical relative of formaldehyde, which is used to embalm bodies, acetaldehyde is 30 times more toxic than alcohol. When a moderate amount of alcohol is consumed, acetaldehyde is converted into a harmless compound called acetic acid. However, when an excess amount of alcohol is consumed, the nutrients required for the conversion to acetic acid are depleted, and acetaldehyde stays in the system and wreaks havoc on the body.
- One of the most damaging activities of acetaldehyde is a process called cross-linking, which “binds up” molecules and hinders normal function. Acetaldehyde is also a potent pro-oxidant that drains your body's stores of antioxidants, B vitamins, and other vital nutrients. The results are dehydration, plummeting blood sugar levels, nutrient deficiencies and cellular damage to vital organs, such as, the liver.
- Thus, it would be desirable to have a product that promotes the beneficial in vivo metabolism of alcoholic beverages and facilitates alcohol degradation into non-toxic substances, such as amino acids.
- The following patents describe various compositions for treating alcoholism, reducing or preventing alcohol intoxication and the like.
- Two U.S. patent Publications No. 2004/0086574 and 2003/0012826 (now U.S. Pat. No. 6,660,293 B2) to Giordano et al. describe a treatment for alcoholism using copper sulfate and a “cocktail” of vitamins, preferably free of iron. Patent Publication No. 2002/0015741 to Bowen, Jr. et al. describes the use of additives such as transition metals (e.g., ammonium iron citrate, ammonium molybdate) for accelerating in vivo oxidation of ethanol to acetic acid.
- U.S. Pat. No. 4,346,082 to Revici describes the use of inorganic sulfur compounds (i.e., ammonium sulfate solution with pH>5) for reducing or preventing alcohol intoxication. U.S. Pat. No. 4,565,689 to Revici describes organic sulfur compounds in treatments to control the cravings for alcohol. U.S. Pat. No. 4,582,705 to Primes describes a composition used to detoxify alcoholics which includes magnesium sulfate, copper ions, etc.
- Herbal and natural remedies for treating alcohol hangovers and remedies to increase alcohol degradation within the body include enzymes and taurine as disclosed by Fuchs et al. in U.S. Pat. No. 6,514,544; calcium compounds from seaweed by Auchincloss in U.S. Pat. No. 6,346,275; herbal teas extracted from leaves, stems, roots or alder and mountain ash trees by Nam in U.S. Pat. No. 5,968,520; herbal or vegetable extracts containing naturally occurring daidzin and diadzein by Duthinh in U.S. Pat. No. 5,547,671 and Capsicum pepper and bark or wood of the poplar tree by Fontaine et al. in U.S. Pat. No. 4,931,277.
- The plethora of hangover remedies and the broad range of anti-intoxication compositions are indicative of the need to find a reliable solution to the problem caused by excessive consumption of alcohol by human beings. The present invention provides an effective formulation to protect against damage to the body caused by excessive alcohol intake.
- In U.S. Pat. Nos. 5,989,595 and 6,242,011 B1 to Cummins, an acidic composition of matter is disclosed that is useful for destroying microorganisms that spoil food, such as fish. The composition of matter, patented by Cummins, is also useful for skin treatment of melanoma and the treatment of other bacteria, and serves as the precursor for the novel composition and method for promoting the beneficial metabolism of alcohol in vivo.
- The first objective of the present invention is to provide an alcohol hangover remedy.
- The second objective of the present invention is to provide an ingestible substance that facilitates metabolic conversion of alcohol to amino acids.
- The third objective of the present invention is to provide a composition of matter that ameliorates certain negative effects of excess alcohol consumption.
- The fourth objective of the present invention is to provide an easy to take dosage that changes bodily alcoholic content into a harmless, perhaps even beneficial, amino acid.
- The fifth objective of the present invention is to provide a composition of matter that reduces the strain on the human liver when metabolizing an excessive amount of alcohol.
- The sixth objective of the present invention is to increase the alcohol degradation capacity of an individual.
- A preferred anti-intoxication composition is made by combining sulfuric acid of approximately 94% purity to approximately 99.9% purity in a 1 to 2 volume ratio with distilled water and ammonium sulfate in a ratio of 2.77 pounds of ammonium sulfate per gallon of distilled water to provide a first mixture, then combining the first mixture in a pressurized vessel at a pressure that is above atmospheric pressure and heating the mixture at a temperature in a range between approximately 200 degrees Fahrenheit and approximately 1200 degrees Fahrenheit, for at least 30 minutes. The first mixture is then cooled and a stabilizer is added. The stabilizer is a portion of the first mixture and is 10 weight percent of the total weight of the first mixture. The first mixture and stabilizer form the second mixture. A compound containing metallic ions to is added to the second mixture to form a third mixture. The third mixture is diluted with water prior to adding sweeteners, flavoring agents and food additives to provide a composition that converts ethanol to amino-ethanoic acid, commonly known as glycine.
- The preferred metallic ions are copper ions, silver ions, zinc ions, magnesium ions and mixtures thereof; available from compounds, such as, but not limited to, copper sulfate, copper sulfate pentahydrate, copper glutamate, zinc oxide, zinc glutamate, magnesium glutamate, magnesium sulfate, silver oxide and silver sulfate.
- In the process of forming the first mixture, it is preferred to apply direct current (DC) voltage during the addition of ammonium sulfate. The DC voltage is in a range from approximately 1 amp to approximately 100 amps, more preferably in a range from approximately 1 amp to approximately 5 amps.
- The sweetener in the anti-intoxication composition can be xylitol, sorbitol and mixtures thereof. The preferred flavoring agent is, but is not limited to, ginger and citrus essence.
- The ratio of water used to form a solution of the compound containing metallic ions to the total weight of the third mixture is in a range between approximately 2% to approximately 75% by weight.
- The preferred food additive is a food grade citric acid, ascorbic acid, sodium benzoate, potassium benzoate, vitamin B6 and mixtures thereof.
- The preferred method of making an anti-intoxication composition that is used to convert ethanol to an amino acid in the human body, includes adding sulfuric acid of approximately 94 percent purity to a first container; heating distilled water in a ratio of twice the volume of the sulfuric acid in a separate container to at least 1400 F; mixing ammonium sulfate in the heated water in a ratio of 2.77 pounds per gallon of water to form a first mixture; simultaneously combining the mixture of sulfuric acid, heated distilled water, and ammonium sulfate (mixture I) in a separate pressurized vessel by injection; heating the pressurized mixture to a temperature in a range between approximately 200° F. and approximately 1200° F. for approximately 30 minutes to form a second mixture; cooling mixture (II) and adding a stabilizer portion of the first mixture to the cooled mixture, wherein the stabilizer comprises approximately 10 weight percent of the total weight of the second mixture; adding a compound containing metallic ions to mixture II to form a third mixture having a stable suspension of metallic ions; diluting the third mixture with water; adding at least one of a sweetener, a flavoring agent and a food additive to form a refreshing liquid; and administering an effective amount of the refreshing liquid to counteract the intoxicating effects of alcohol consumption in a human being.
- The preferred metallic ions are copper ions, silver ions, zinc ions, magnesium ions and mixtures thereof available from compounds including, but not limited to, copper sulfate, copper sulfate pentahydrate, copper glutamate, zinc oxide, zinc glutamate, magnesium glutamate, magnesium sulfate, silver oxide and silver sulfate.
- The preferred sweetener is xylitol, sorbitol and mixtures thereof. The preferred flavoring agent is ginger and citrus essence.
- The ratio of water used to form a solution of the compound containing metallic ions to the total weight of the third mixture is in a range between approximately 2% to approximately 75% by weight.
- The preferred food additives are citric acid, ascorbic acid, sodium benzoate, potassium benzoate, vitamin B6 and mixtures thereof.
- The present invention provides an anti-intoxication composition comprising metallic salts, sulfuric acid, ammonium sulfate, a sweetener, flavoring agents, food additives and water wherein a refreshing liquid, paste, gel or capsule is formed that facilitates the metabolism of ethanol to an amino acid, namely, amino-ethanoic acid, commonly known as, glycine. The ethanol can be in a pure form or as found in wine, beer or hard liquor.
- Further objects and advantages of this invention will be apparent from the following detailed description of a presently preferred embodiment, which is illustrated schematically in the accompanying drawings.
-
FIG. 1 is a graph showing the effect of PHB0020 on pathogenic and spoilage bacterial isolates exposed for 2 minutes. -
FIG. 2 is a graph showing the logarithm of reductions in bacterial colony levels. -
FIG. 3 shows the range alcohol intoxication symptoms as defined by blood alcohol concentration (BAC). - Before explaining the disclosed embodiment of the present invention in detail, it is to be understood that the invention is not limited in its application to the details of the particular arrangement shown since the invention is capable of other embodiments. Also, the terminology used herein is for the purpose of description and not of limitation. It would be useful to discuss the meanings of some words used herein and their applications before discussing the composition of matter and method of using and making the same: PHB0020—Copper sulfate pentahydrate and/or other forms of copper ions, and silver sulfate and/or other forms of silver ions added to pHarlo for the antimicrobial, anti-bacterial additive of the present invention.
-
- pHarlo—composition of matter claimed in U.S. Pat. Nos. 5,989,595 and 6,242,001 B1 to Cummins and incorporated herein by reference and more completely described below.
- Salmonella—Salmonella typhimurium, a pathogen
- Listeria—Listeria monocytogenes, a pathogen
- Staph—Staphylococcus aureus, a pathogen
- E-coli—Escherichia coli, indicator bacteria
- Pseudomonas—Pseudomonas fluorescens, spoilage bacteria
- Shewanella—Shewanella putrefaciens, spoilage bacteria
- BAC—stands for Blood Alcohol Concentration and is used to assess degree of intoxication. BAC is defined as grams of alcohol per deciliter of blood.
- The acidic composition of matter and method of making are similar to that described in U.S. Pat. Nos. 5,989,595 and 6,242,011 B1 to Cummins and are incorporated herein by reference.
- First, a pressurized vessel is selected that includes a cooling jacket and no electrode attachments; however, the preferred pressurized vessel is fitted with two electrodes, a cathode and anode, to provide a direct current (DC) voltage one (1) foot above the bottom of the container. The electrodes are spaced approximately three (3) feet apart.
- The processing steps of the present invention comprise combining sulfuric acid with purity in a range from approximately 94% to approximately 99.9%, in a 1 to 2 volume ratio with distilled water and ammonium sulfate in a ratio of 2.77 pounds of ammonium sulfate per gallon of distilled water to provide mixture (I). The mixture (1) is combined in a pressurized vessel having preferably two strategically placed electrodes, a cathode and anode. During the addition of ammonium sulfate, a direct current (DC) voltage is applied to the mixture. The voltage is applied in a range from approximately one (1) amp to approximately 100 amps, preferably between approximately 1 amp and approximately 5 amps. The mixture is then heated under pressure in a range of from approximately 1 pound per square inch (psi) to approximately 15 psi above atmospheric pressure. Heating of the mixture is in a range of from approximately 200° Fahrenheit (F.) to approximately 1200° F., preferably from approximately 800° F. to approximately 900° F. for approximately 30 minutes. With the application of heat and pressure as specified above, it is understood by persons skilled in the art, that a judicious selection of temperature, time and pressure is required and should be adjusted to maintain a safe chemical reaction.
- After cooling the mixture, a stabilizer is added. The stabilizer is a portion of mixture (I) prior to heating in the pressure vessel. The quantity of stabilizer used is approximately 10 weight percent of the total weight of mixture (1). The resulting acidic composition is useful for destroying microorganisms, having a pH of negative 3 (−3). The inventive step of the present invention requires the addition of compounds containing metallic ions for the extensive antimicrobial properties discussed herein. The following physical and chemical properties are observed when undiluted.
- pH=−3 which was determined by a non acidified hydrogen proton count with the data corrected for any electrode type errors, and was performed by EFE&H & Associates, an EPA (Environmental Protection Agency) approved laboratory in Pearland, Tex.
-
- stability of metallic ions in solution: from approximately 0 pH up to approximately 9 pH
- stability of metallic ions with temperature: from approximately 32° F. to the point of vaporization or approximately 212° F.
- Various other compounds with metallic ions may be substituted for copper sulfate pentahydrate. The following metal salts are suitable substitutes:
- Copper sulfate, copper glutamate, zinc oxide, zinc glutamate, magnesium glutamate, magnesium sulfate, silver sulfate, silver oxide, and combinations thereof.
- Referring now to the composition of pHarlo Blue 0020, hereinafter referred to as PHB0020, it is an antimicrobial, anti-bacterial agent, which has a formulation that is generally recognized as safe (GRAS) by the US Food and Drug Administration. The composition is listed below:
Ingredient Percentage Copper Sulfate 16.4 Pentahydrate Sulfuric Acid 9.9 (processing aid) Ammonium 2.2 sulfate Distilled water 71.5
The ingredients form a concentrate, which is combined in small amounts of less than 0.10 milliliters (ml) with 1 gallon of water to make PHB00200. - Example 1, Table I,
FIG. 1 , andFIG. 2 provide greater detail on the use and effectiveness of PHB0020 as an antimicrobial agent. - In processing plants for poultry and animal products, it is customary to use various water treatment processes, such as a scalding tank, spray bath, final rinse and chill water tank. The scalding tank is used to dip poultry prior to the removal of feathers; other animals are dipped to remove the outer coating of fur or hair. The scalding process permits cross contamination and spread of pathogens. It is important for the safety of the human food supply to provide an additive that can be used in water treatments to inhibit the growth and spread of pathogens and deleterious bacteria. The ideal additive would not evaporate at boiling point temperatures, would not be destroyed by high temperatures and would not be bound by organic material, such as blood and feces and rendered useless.
- The effect of PHB0020 on pathogenic, indicator, and spoilage populations of bacteria associated with broiler chicken carcasses in a poultry scald water application is determined in one embodiment of the present invention.
- First, scalder water was collected from the overflow or entrance end of a commercial poultry scalder. The water is sterilized or autoclaved to eliminate all populations of bacteria and bacterial spores to avoid interference during the study. The autoclaved scalder water is evaluated chemically and compared to raw scalder water to ensure that the organic material demand in raw and autoclaved scalder water is similar.
- Next, sets of test tubes are prepared by adding 9 milliliters (ml) of sterilized scalder water to sterile polystyrene test tubes. One set is prepared as controls by adding 9 ml of sterilized scalder water to tubes. One set is prepared by adding 9 ml of sterilized scalder water and PHB0020 (the disinfectant) until the pH of 2.2 is achieved.
- Each bacterium is exposed, one at a time, to the sterilized scalder water with PHB0020 sanitizer for approximately 2 minutes at approximately 130° F. (55° C.) to mimic scalding.
- After the exposure period, one ml of the suspension was enumerated using the aerobic plate count method by pour plating and incubating at approximately 95° F. (35° C.) for 48 hours.
- Table I below records microbial growth results in a scalder water project wherein sterilized water was heated to scalding temperatures of in a range of from approximately 120° F. (49° C.) to approximately 140° F. (60° C.), preferably to a temperature of approximately 130° F. (55° C.). Various concentrations of PHB0020 are added in a range between approximately 0.4 parts per million (ppm) to approximately 0.8 ppm, preferably at approximately 0.6 ppm and colonies of pathogens, indicator bacteria and spoilage bacteria are exposed to the treated scalder water.
TABLE I Scalder Water Project Control Colonies forming Log of Growth after Exposure Sample No.: Bacteria Units Reduction to Treated Scalder Water Bacteria: Salmonella typhimurium 1 430 2.633468 negative (no growth) 2 880 2.944483 negative 3 970 2.986772 negative 4 450 2.653213 negative 5 620 2.792392 negative 6 700 2.845098 negative 7 1140 3.056905 negative 8 620 2.792392 negative 9 580 2.763428 negative Bacteria: Staphylococcus aureus 1 530 2.724276 negative (no growth) 2 550 2.740363 one (1) colony growing 3 580 2.763428 negative 4 500 2.698970 negative 5 540 2.732394 negative 6 420 2.623249 negative 7 530 2.724276 negative 8 480 2.681241 one (1) colony growing 9 470 2.672098 negative Bacteria: Pseudomonas fluorescens 1 540 2.73234 negative 2 880 2.944483 negative 3 790 2.897627 negative 4 620 2.792392 negative 5 1120 3.049218 negative 6 790 2.897627 one (1) colony growing 7 5200 3.716003 negative 8 1360 3.133539 negative 9 1040 3.017033 negative Bacteria: Listeria monocytogenes 1 1720 3.235528 five (5) colonies growing 2 1840 3.264818 six (6) colonies growing 3 1440 3.158362 negative (no growth) 4 1820 3.260071 five (5) colonies growing 5 1440 3.158362 one (1) colony growing 6 1880 3.274158 negative 7 1720 3.235528 negative 8 1720 3.235528 negative 9 1740 3.240549 negative Bacteria: Shewanella putrefaciens 1 50 1.698970 negative (no growth) 2 50 1.698970 negative 3 60 1.778151 negative 4 20 1.301030 negative 5 50 1.698970 negative 6 70 1.845098 negative 7 80 1.903090 negative 8 20 1.301030 negative 9 30 1.477121 negative Bacteria: Escherichia coli 1 15100000 7.178977 460 colonies growing 2 12900000 7.110590 negative (no growth) 3 13300000 7.123852 32 colonies growing 4 12200000 7.086360 1170 colonies growing 5 13400000 7.127105 4700 colonies growing 6 12200000 7.086360 57 colonies growing 7 14200000 7.152288 900 colonies growing 8 13600000 7.133539 410 colonies growing 9 7600000 6.880814 37 colonies growing - Referring now to
FIG. 1 , the graph shows the effect of PHB0020 on pathogenic and spoilage bacteria identified in the table above. The graph is divided in two sections, on the left is the control showing the logarithm of colony forming units for each bacterium and on the right is the graph of colony forming units after each bacterium is exposed for 2 minutes to scalder water treated with PHB0020. The graph shows that Listeria, a gram-positive bacterium, is hard to kill and E coli, a very prolific bacterium, has the highest reduction after a 2 minute exposure. - In
FIG. 2 , the graph shows the logarithm of the reduction of bacterial levels for each bacterium. In most cases the log of colony forming units is less than three, with the most prolific bacterium, E coli having a log of less than five. - Thus, PHB0020 functions as an antimicrobial agent, disinfectant, or sanitizer and is extremely effective for eliminating populations of pathogenic, indicator and spoilage bacteria in commercial scalder water under industrial scalding conditions. PHB0020 is an effective means for controlling bacteria in scalder water and may be used for controlling cross-contamination during scalding. Disinfection of poultry scalder water is crucial because it is the first area within the plant in which birds are immersed in a common bath wherein bacteria can be transferred from bird to bird.
- The efficacy of PHB0020 as an antimicrobial agent additive and active ingredient in an alcohol hangover remedy is described in greater detail below.
- However, when PHB0020 is used in the following range, the resulting alcohol hangover treatment is found to be effective, based on individual metabolic rates.
Use Levels in Milligrams per Liter (mg/l) Application for PHB0020: Range Target Alcohol Hangover Remedy 0.5 to 5.50 mg/l 1.2 mg/l - A mixture of the composition of the present invention having approximately 1.2 mg/l of PHB0020 was prepared at room temperature; using the formulation in Table II below. It is understood by persons skilled in the art that variations in the amount of each ingredient are within the scope of the present invention. Thus, a reasonable range of ingredients, within ±5% of the stated value, can be used to adjust taste and desired effectiveness. The PHB0020 ingredient is used in a range of 0.5 mg/l to 5.50 mg/l.
TABLE II Hangover Remedy Drink Ingredient Percentage PHB0020 0.120 Citric Acid 0.065 Ascorbic Acid 0.100 Sodium benzoate 0.280 Potassium 0.016 benzoate Ginger 0.400 Xylitol 18.420 Vitamin B6 0.098 Polyglycol 0.338 Sorbitol 0.650 Deionized Water 79.513 Total 100.000 - The composition of the present invention is prepared by first mixing PHB0020 which contains metallic ions with deionized water and then adding in sequence the edible inorganic acids: citric acid and ascorbic acid; the alkali-metal benzoate compounds: sodium benzoate and potassium benzoate; ginger; xylitol; and Vitamin B6. The ingredients are mixed in the percentages given in Table II above. The mixture is thoroughly stirred until the metallic ions in the PHB0020 starting material are completely blended and uniformly suspended. The liquid mixture can be used as a refreshing drink or concentrated and used as a paste, gel, or capsule that is diluted by fluids in the stomach cavity.
- Below is a brief explanation of alcohol metabolism in vivo to provide a clearer understanding of the present invention. The metabolism of alcohol takes place in both the stomach cavity and in the liver. When an alcoholic beverage is swallowed, it passes through the stomach into the small intestine where the ethanol is rapidly absorbed and distributed throughout the body. The ethanol enters body tissues in proportion to the body's water content. Therefore, more ethanol is found in the blood and the brain than in muscle or fat tissue. The ethanol is greatly diluted by body fluids. For example, a 1-ounce shot of 100-proof whiskey, which contains 0.5 fluid ounces of ethanol (approximately 15 milliliters (ml), is diluted 5000-fold in a 150 pound human, producing a 0.02% blood alcohol concentration (BAC).
- Ethanol is toxic, and the body begins to dispose of it immediately upon its consumption. Over 90% of it is processed by the liver. In the liver, the alcohol dehydrogenase (ADH) enzyme converts ethanol into acetaldehyde, which is itself toxic. Acetaldehyde is then destroyed by the ADH enzyme, which converts acetaldehyde to acetate ions. When ethanol is converted to acetaldehyde and acetaldehyde is converted to acetate ions, excess hydrogen atoms are released and immediately picked up by another biologically important compound in the liver, nicotinamide-adenine dinucleotide (NAD) whose function is to carry hydrogen atoms. NAD is converted to NADH. NADH must be recycled to NAD for the disposal of ethanol to continue. If the amount of ethanol consumed is not great, the recycling can keep up with the disposal of ethanol. Disposal of ethanol occurs in both the stomach and the liver. In the stomach, the acetate is broken down into water and carbon dioxide, both of which are secreted. In the liver, the acetate is converted to energy by way of the citric acid cycle and into fat through fatty acid synthesis. The composition of the present invention increases the disposal of alcohol in the stomach; thus, reducing the strain on the human liver when metabolizing an excessive amount of alcohol.
- Until a recent focus on substances to expedite in vivo alcohol degradation, only time could sober up a person—not black coffee, cold showers, exercise, or any other common remedies. Alcohol leaves the body of virtually everyone at a constant rate of about 0.015 percent of blood alcohol content (BAC) per hour. Thus, a person with a BAC of 0.015 would be completely sober in an hour, while a person with a BAC of ten times that (0.15) would require 10 hours to become completely sober. This is true regardless of sex, age, weight and similar factors. The quantity of alcohol that needs to be consumed to reach a specific BAC level does depend on a person's weight and the speed of consumption. For example, if a person weighing 150 pounds consumes a fifth gallon of 100-proof whiskey within 10 minutes, the blood alcohol level could reach 0.5% and lead to death.
- The toxicity of alcohol is clearly evident when the consumption of ethanol far exceeds the body's disposal capacity.
- Five samples of 100% pure ethanol, 100 milliliters (ml) in each sample, were measured into a glass beaker. A precursor of the anti-intoxication composition of the present invention was prepared with concentrations of PHB0020 in a range from 0.01 mg/l to 0.05 mg/l. The results are shown in Table III below. Readings of the percent recovery were made after initial contact of the ethanol sample with the anti-intoxication composition of the present invention.
TABLE III Pure Ethanol Precursor Anti-intoxication Composition % Recovery of Ethanol 0.5% solution 98.6 (.001 mg/l PHB0020) 1.0% solution 95.4 (.002 mg/l PHB0020) 2.0% solution 96.2 (.003 mg/l PHB0020) 4.0% solution 94.6 (.004 mg/l PHB0020) 10.0% solution 85.5 (.005 mg/l PHB0020) - When a 10% solution of the precursor anti-intoxication composition of the present invention with 0.005 mg/l of PHB0020 is used, the least amount of ethanol is recovered. This led to the formulation of the anti-intoxication composition of the present invention, namely, more than a 100-fold increase in the milligrams per liter (mg/1) of PHB0020. Thus, the PHB0020 ingredient is preferably used in a range of approximately 0.5 mg/l to approximately 5.50 mg/l in the anti-intoxication composition of the present invention.
- The recovered products in Example 3 are ethanol and amino-ethanoic acid, commonly known as, glycine, a non-essential amino acid.
- The series of tests on pure ethanol confirmed the conversion of ethanol to an amino acid; the predominant amino acid conversion product is a carboxylic acid namely, amino ethanoic acid, as shown in Equation (1) below:
One of the hydrogen atoms of the second carbon atom is substituted with an amino group (NH2) in the presence of the PHB0020 mixture, which includes a processed mixture of metallic salts, sulfuric acid, and transition metal sulfates. The primary reaction product is H2NCH2COOH; the simplest amino ethanoic acid or “glycine.” - Glycine is one of the major inhibitory neurotransmitters in the brain. Glycine helps build up glycogen levels in the liver helps make DNA, skin proteins, collagen and phospholipids, which make cell membranes. Glycine also participates in the major energy producing biochemical reaction in the body. Thus, the conversion of alcohol to glycine has potentially significant health benefits.
- One serving of beer (12 fluid ounces (fl oz), one serving of Chardonnay (5 fl oz) and one serving of Cabernet Sauvignon (5 fl oz) were mixed with varying quantities of the anti-intoxication composition of the present invention containing 10.0% PHB0020. The servings were then analyzed for the quantity of ethanol before and after the addition of the anti-intoxication composition of the present invention. The results are shown in Table IV below.
TABLE IV Beer and Wine Hangover Hangover No Drink Drink Alcoholic Treatment 25 ml 50 ml Beverage Quantity % Ethanol Beer 12 fl oz 4.46 4.01 4.00 Chardonnay 5 fl oz 9.50 9.18 8.17 Cabernet 5 fl oz 10.60 9.35 9.20 Sauvignon
The 50 ml addition of anti-intoxication composition of the present invention to the beer and wine samples resulted in the greater reduction in ethanol content on contact. - Twenty individuals voluntarily agreed to participate in testing the anti-intoxication composition of the present invention before and after consuming alcoholic beverages. Ten individuals were given 50 ml of the anti-intoxication composition of the present invention before consuming 1 or 2 alcoholic drinks and did not begin to demonstrate certain and typical early manifestations of the effects of the alcohol, such as that of a person with a 0.05 BAC described in
FIG. 3 . Ten individuals were given 1 or 2 alcoholic drinks and began to demonstrate certain and typical early manifestations of the effects of the alcohol as described inFIG. 3 with a BAC between 0.05 and 0.10. The ten who were showing signs of inebriation, were given 50 ml of the anti-intoxication composition of the present invention and within approximately 30 to approximately 40 minutes were not exhibiting any of the typical and usual manifestations of the effects of alcohol. - The novel composition of the present invention is effective in preventing intoxication and offsetting the toxic effects of alcohol on those occasions when there is liberal indulgence in alcoholic drinks, beyond just a one or two drink limit.
- While the invention has been described, disclosed, illustrated and shown in various terms of certain embodiments or modifications which it has presumed in practice, the scope of the invention is not intended to be, nor should it be deemed to be, limited thereby and such other modifications or embodiments as may be suggested by the teachings herein are particularly reserved especially as they fall within the breadth and scope of the claims here appended.
Claims (20)
1. An anti-intoxication composition made by the process of:
(a) combining sulfuric acid of approximately 94% purity to approximately 99.9% purity in a 1 to 2 volume ratio with distilled water and ammonium sulfate in a ratio of 2.77 pounds of ammonium sulfate per gallon of distilled water to provide mixture (I);
(b) combining the mixture (I) in a pressurized vessel at a pressure that is above atmospheric pressure and heating the mixture at a temperature in a range between approximately 200 degrees Fahrenheit and approximately 1200 degrees Fahrenheit, for at least 30 minutes;
(c) cooling the mixture;
(d) adding a stabilizer which is a portion of mixture (I) and comprises 10 weight percent of the total weight of mixture (I), thereby forming mixture (II);
(e) adding a compound containing metallic ions to mixture (II) to form mixture (III);
(f) diluting mixture (III) with water; and
(g) adding at least one of a sweetener, a flavoring agent and a food additive to provide a composition that converts ethanol to amino-ethanoic acid.
2. The anti-intoxication composition made by the process of claim 1 , wherein the metallic ions are selected from the group consisting of copper ions, silver ions, zinc ions, magnesium ions and mixtures thereof.
3. The anti-intoxication composition made by the process of claim 1 , wherein the compound containing metallic ions is selected from at least one of: copper sulfate, copper sulfate pentahydrate, copper glutamate, zinc oxide, zinc glutamate, magnesium glutamate, magnesium sulfate, silver oxide and silver sulfate.
4. The anti-intoxication composition made by the process of claim 1 , further comprising the step of applying direct current (DC) voltage to mixture (I) during the addition of ammonium sulfate.
5. The anti-intoxication composition made by the process of claim 4 , wherein the DC voltage is in a range from approximately 1 amp to approximately 100 amps.
6. The anti-intoxication composition made by the process of claim 5 , wherein the DC voltage is in a range from approximately 1 amp to approximately 5 amps.
7. The anti-intoxication composition made by the process of claim 1 wherein the sweetener is selected from the group consisting of xylitol, sorbitol and mixtures thereof.
8. The anti-intoxication composition made by the process of claim 4 , wherein the ratio of the water used to form a solution of the compound containing metallic ions to the total weight of mixture (III) is in a range between approximately 2% to approximately 75% by weight.
9. The anti-intoxication composition made by the process of claim 1 , wherein the flavoring agent is selected from the group consisting of ginger and citrus essence.
10. The anti-intoxication composition made by the process of claim 1 , wherein the food additive is selected from the group consisting of citric acid, ascorbic acid, sodium benzoate, potassium benzoate, vitamin B6 and mixtures thereof.
11. A method of making an anti-intoxication composition for conversion of ethanol to an amino acid in the human body, comprising the steps of:
(a) adding sulfuric acid of approximately 94 percent purity to a first container;
(b) heating distilled water in a ratio of twice the volume of the sulfuric acid in a separate container to at least 140° F.;
(c) mixing ammonium sulfate in the heated water in a ratio of 2.77 pounds per gallon of water to form mixture (I);
(d) simultaneously combining the mixture of sulfuric acid, heated distilled water, and ammonium sulfate (mixture I) in a separate pressurized vessel by injection;
(e) heating the pressurized mixture to a temperature in a range between approximately 200° F. and approximately 1200° F. for approximately 30 minutes to form mixture (II);
(f) cooling mixture (II) and adding a stabilizer portion of mixture (I) to the cooled mixture, wherein the stabilizer comprises approximately 10 weight percent of the total weight of mixture (II);
(g) adding a compound containing metallic ions to mixture II to form mixture (III), a stable suspension of metallic ions;
(h) diluting mixture III with water;
(i) adding at least one of a sweetener, a flavoring agent and a food additive to form a refreshing liquid; and
(j) administering an effective amount to counteract the intoxicating effects of alcohol consumption in a human being.
12. The method of claim 11 , wherein the metallic ions are selected from the group consisting of copper ions, silver ions, zinc ions, magnesium ions and mixtures thereof.
13. The method of claim 11 , wherein the compound containing metallic ions is selected from at least one of: copper sulfate, copper sulfate pentahydrate, copper glutamate, zinc oxide, zinc glutamate, magnesium glutamate, magnesium sulfate, silver oxide and silver sulfate.
14. The method of claim 11 , wherein the sweetener is selected from the group consisting of xylitol, sorbitol and mixtures thereof.
15. The method of claim 11 , wherein the ratio of water used to form a solution of the compound containing metallic ions to the total weight of mixture (III) is in a range between approximately 2% to approximately 75% by weight.
16. The method of claim 11 , wherein the flavoring agent is selected from the group consisting of ginger and citrus essence.
17. The method of claim 11 , wherein the food additive is selected from the group consisting of citric acid, ascorbic acid, sodium benzoate, potassium benzoate, vitamin B6 and mixtures thereof.
18. An anti-intoxication composition comprising metallic salts, sulfuric acid, ammonium sulfate, a sweetener, flavoring agents, food additives and water wherein a refreshing material is formed that facilitates the metabolism of ethanol to an amino acid.
19. The anti-intoxication composition of claim 18 , wherein the ethanol is made available from at least one of wine, beer or hard liquor.
20. The anti-intoxication composition of claim 18 , wherein the amino acid is amino-ethanoic acid, commonly known as, glycine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/065,652 US20050191395A1 (en) | 2004-02-26 | 2005-02-24 | Hangover remedy and alcohol abatement composition |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54799104P | 2004-02-26 | 2004-02-26 | |
PCT/US2004/027104 WO2005091739A2 (en) | 2004-02-26 | 2004-08-20 | Antimicrobial composition for pre-harvest and post-harvest treatment of plants and animals |
WOPCT/US04/27104 | 2004-08-20 | ||
PCT/US2004/043714 WO2005092358A1 (en) | 2004-02-26 | 2004-12-30 | Oral health care drink and method for reducing malodors |
WOPCT/US04/43714 | 2004-12-30 | ||
US11/065,652 US20050191395A1 (en) | 2004-02-26 | 2005-02-24 | Hangover remedy and alcohol abatement composition |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050191395A1 true US20050191395A1 (en) | 2005-09-01 |
Family
ID=34910969
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/922,604 Active - Reinstated 2025-05-06 US7192618B2 (en) | 2004-02-26 | 2004-08-20 | Antimicrobial composition for pre-harvest and post-harvest treatment of plants and animals |
US11/065,652 Abandoned US20050191395A1 (en) | 2004-02-26 | 2005-02-24 | Hangover remedy and alcohol abatement composition |
US11/674,588 Abandoned US20070264398A1 (en) | 2004-02-26 | 2007-02-13 | Antimicrobial composition for pre-harvest and post-harvest treatment of plants and animals |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/922,604 Active - Reinstated 2025-05-06 US7192618B2 (en) | 2004-02-26 | 2004-08-20 | Antimicrobial composition for pre-harvest and post-harvest treatment of plants and animals |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/674,588 Abandoned US20070264398A1 (en) | 2004-02-26 | 2007-02-13 | Antimicrobial composition for pre-harvest and post-harvest treatment of plants and animals |
Country Status (6)
Country | Link |
---|---|
US (3) | US7192618B2 (en) |
EP (3) | EP1791578A2 (en) |
CN (4) | CN101076322A (en) |
CA (3) | CA2599345A1 (en) |
MX (3) | MXPA06009797A (en) |
WO (3) | WO2005091739A2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD564303S1 (en) | 2006-09-22 | 2008-03-18 | Jm Zell Partners, Ltd | Wine illuminator |
USD569692S1 (en) | 2006-01-25 | 2008-05-27 | Jm Zell Partners, Ltd. | Wine illuminator |
USD569693S1 (en) | 2006-01-25 | 2008-05-27 | Jm Zell Partners, Ltd | Wine illuminator |
US20080151528A1 (en) * | 2006-12-21 | 2008-06-26 | J.M. Zell Partners Ltd. | Wine Illuminator |
US20080292674A1 (en) * | 2007-05-18 | 2008-11-27 | Crudden Joseph J | Bioactive agrichemical compositions and use thereof |
US20140072652A1 (en) * | 2010-11-09 | 2014-03-13 | Cms Innovative Technologies, Inc. | Multifunctional produce wash |
US9295254B2 (en) | 2011-12-08 | 2016-03-29 | Sciessent Llc | Nematicides |
WO2019055756A1 (en) * | 2017-09-14 | 2019-03-21 | Iti Technologies, Inc. | Anti-intoxication composition and process |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6242011B1 (en) * | 1999-08-05 | 2001-06-05 | Barry W. Cummins | Acidic composition of matter for use to destroy microorganisms |
US8012511B1 (en) * | 2005-12-02 | 2011-09-06 | Contact Marketing Solutions, Llc | Acidic composition of matter for use to destroy microorganisms |
US8691285B2 (en) * | 1996-03-08 | 2014-04-08 | Cms Innovative Technologies, Inc. | Anti-microbial applications for acidic composition of matter |
US20080166424A1 (en) * | 2004-02-26 | 2008-07-10 | Mixon Stephen P | Compositions and methods for treatment of diseases of the foot of an animal |
AU2006314306A1 (en) * | 2005-11-17 | 2007-05-24 | Remedy Research Limited | Pathogen - controlling products |
US20070190175A1 (en) * | 2005-12-08 | 2007-08-16 | Tasker Products Ip Holding Corp | Skin care composition for dermatological disorders |
US20090074881A1 (en) * | 2006-05-02 | 2009-03-19 | Bioneutral Laboratories Corporation Usa | Antimicrobial cidality formulations with residual efficacy, uses thereof, and the preparation thereof |
US7648643B1 (en) * | 2006-06-21 | 2010-01-19 | Phitex, L.L.L.P. | Metal recovery process and method |
US20080112988A1 (en) * | 2006-11-14 | 2008-05-15 | Ancient Stones, Inc. | Composition and method for cosmetic vitalization and stabilization |
WO2009055799A2 (en) * | 2007-10-25 | 2009-04-30 | Kenneke Eli L | Compositions and methods for treatment of diseases of the foot of an animal |
WO2009156972A2 (en) * | 2008-06-27 | 2009-12-30 | Ecolab Inc. | Methods and systems for reconditioning food processing fluids |
US7825082B2 (en) | 2008-07-11 | 2010-11-02 | S&B Worldwide Corporation | Highly protonated, supercharged, low pH, non-corrosive composition |
US20100233291A1 (en) | 2009-03-12 | 2010-09-16 | Dennis Smithyman | Animal lesion treatment and prevention formulations and methods |
US20100233289A1 (en) * | 2009-03-12 | 2010-09-16 | Dennis Smithyman | Antimicrobial acid formulation |
CN101756042B (en) * | 2010-03-12 | 2012-07-04 | 广州英赛特生物技术有限公司 | Application of cupric glutamate or derivatives thereof as feed additive for promoting animal growth |
US20120114764A1 (en) * | 2010-11-09 | 2012-05-10 | Contact Marketing Solutions, Llc | Multifunctional produce wash |
US20130295195A1 (en) * | 2012-05-02 | 2013-11-07 | Contact Marketing Solutions Innovative Technologies | Aqueous additive for poultry water |
US9161957B2 (en) * | 2012-08-03 | 2015-10-20 | Life Well Lived, Llc | Compositions and methods for reducing blood alcohol content |
CN103109978B (en) * | 2013-01-06 | 2016-08-03 | 贵州利德高科技发展有限公司 | A kind of amino acid nano-silver liquid and preparation method thereof and safety is anosis raise pigs on application |
US10076123B1 (en) | 2015-02-19 | 2018-09-18 | Zeco, Inc. | Method for reduction in microbial activity in red meat |
US10093564B2 (en) | 2015-06-19 | 2018-10-09 | Earth Science Laboratories | Chelating base product for use in water-based system treatments |
US10662093B2 (en) | 2015-06-19 | 2020-05-26 | Earth Science Laboratories | Agriculture treatment solution with chelating base product |
US20180228189A1 (en) | 2017-02-14 | 2018-08-16 | Kraft Foods Group Brands Llc | Process for maintaining freshness of vegetable pieces |
US20200239324A1 (en) | 2019-01-28 | 2020-07-30 | ITI Technolgies, Inc. | Solubility Enhancing Composition |
CN109549037A (en) * | 2019-01-31 | 2019-04-02 | 北京富海科技发展有限公司 | It is a kind of for sobering up and preventing the drink being still drank after a night |
US11432569B2 (en) | 2019-10-31 | 2022-09-06 | Iti Technologies, Inc. | Domestic animal water and feed modifying compositions |
US11653652B2 (en) | 2020-06-30 | 2023-05-23 | Iti Technologies, Inc. | Antimicrobial compositions and uses thereof |
WO2022006242A1 (en) * | 2020-06-30 | 2022-01-06 | Iti Technologies, Inc. | Antimicrobial compositions and uses thereof |
GB2623098A (en) * | 2022-10-05 | 2024-04-10 | Rotam Agrochem Int Co Ltd | Aqueous composition containing a copper salt and use thereof as a fungicide or bactericide |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4338343A (en) * | 1980-06-04 | 1982-07-06 | Pennwalt Corporation | Liquid anti-microbial treatments for storage grain with ammonium bisulfite and a disproportionation product thereof |
US4346082A (en) * | 1980-01-04 | 1982-08-24 | The Vinoxen Company | Method of employing therapeutic composition comprising ammonium or substituted ammonium compounds for treatment of alcoholism |
US4500517A (en) * | 1981-12-07 | 1985-02-19 | H. B. Fuller Co. | Antimicrobial composition for a semipermeable membrane |
US4565689A (en) * | 1985-04-12 | 1986-01-21 | Wirth Maschinen-Und Bohrgerate-Fabrik Gmbh | Method for treating the effects of alcohol |
US4582705A (en) * | 1982-07-12 | 1986-04-15 | Leonard Primes | Composition for detoxification |
US4931277A (en) * | 1986-05-12 | 1990-06-05 | Michel Fontaine | Capsicum and populas useful for the treatment of alcoholic toxicomania |
US5547671A (en) * | 1995-09-20 | 1996-08-20 | Duthinh; Phu | Anti-intoxication composition |
US5912030A (en) * | 1995-10-16 | 1999-06-15 | Leaf Inc. | Comestible products having extended release of addititives and method of making |
US5968520A (en) * | 1996-11-07 | 1999-10-19 | Nam; Jong Hyun | Natural teas for taking off the effects of drink and process for the production thereof |
US5989595A (en) * | 1996-03-08 | 1999-11-23 | Cummins; Barry W. | Acidic composition of matter for use to destroy microorganisms |
US5997602A (en) * | 1995-06-22 | 1999-12-07 | Kemira Agro Oy | Aqueous fertilzer suspension containing at least phosphate ions and calcium or magnesium ions and a use of the suspension |
US6242011B1 (en) * | 1999-08-05 | 2001-06-05 | Barry W. Cummins | Acidic composition of matter for use to destroy microorganisms |
US20020015741A1 (en) * | 2000-06-12 | 2002-02-07 | Bowen Ward Beryl | Method and composition for the accelerated in vivo removal of ethanol |
US6346275B1 (en) * | 1997-02-03 | 2002-02-12 | Aquacal Limited | Calcareous material |
US20030012826A1 (en) * | 2001-06-29 | 2003-01-16 | Giordano John A. | Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects |
US6514544B2 (en) * | 1998-11-19 | 2003-02-04 | Jhs-Privatstiftung | Beverage for increasing the body's capacity to break down alcohol and method thereof |
US6565893B1 (en) * | 1999-02-17 | 2003-05-20 | Worldwide Pure Water, Inc. | Process for preparing a disinfectant containing suspended metals |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3954453A (en) * | 1973-09-25 | 1976-05-04 | Porth Luis De La Pena | Recovery of copper from ammoniacal copper sulfate solution |
DE2530487A1 (en) * | 1975-07-09 | 1977-01-27 | Erfindergesellschaft Fresenius | WATER SANITIZER AND METHOD FOR MANUFACTURING THEREOF |
ES2005784A6 (en) * | 1988-02-22 | 1989-03-16 | Desarrollo Tecnico Ind S A Soc | Process for the preparation of aqueous solutions of 2-hydroxy-4-methylthio-butyric acid. |
MX9304245A (en) * | 1993-07-14 | 1995-01-31 | Celanese Mexicana Sa | CONTINUOUS IMPROVED PROCESS FOR THE MANUFACTURE OF TUBULAR WRAPS FOR FOODS. |
US5560821A (en) * | 1993-09-02 | 1996-10-01 | Leo; Enzo | Waste water treatment system |
US5961843A (en) * | 1994-10-05 | 1999-10-05 | Toto Ltd. | Antimicrobial solid material, process for producing the same, and method of utilizing the same |
US5997911A (en) * | 1996-08-27 | 1999-12-07 | Brinton Veterinary Supply, Inc. | Composition and method for reducing diarrhea in poultry and swine |
US6242001B1 (en) * | 1998-11-30 | 2001-06-05 | Mcneil-Ppc, Inc. | Method for producing dispersible sterol and stanol compounds |
AU2728900A (en) * | 1999-01-19 | 2000-08-07 | Stericon, L.L.C. | Multi-purpose acid compositions |
CA2382449A1 (en) * | 1999-08-31 | 2001-03-08 | Remedy Research Limited | Metal-containing compositions, preparations and uses |
US6333004B1 (en) * | 2000-01-10 | 2001-12-25 | Dan M. Sheldon | Apparatus and method for removing microbial contaminants from a flowing fluid |
JP2001347274A (en) * | 2000-04-04 | 2001-12-18 | Kokichi Aoki | Water quality improving agent, and apparatus and method for improving water quality |
US6506737B1 (en) * | 2000-04-05 | 2003-01-14 | Ecolab, Inc. | Antimicrobial phosphonium and sulfonium polyhalide compositions |
US7150884B1 (en) * | 2000-07-12 | 2006-12-19 | Ecolab Inc. | Composition for inhibition of microbial growth |
US7163709B2 (en) * | 2001-12-20 | 2007-01-16 | Robert Cook | Composition for disinfection of plants, animals, humans, byproducts of plants and animals and articles infected with pathogens and method of producing and application of same |
DE10217649A1 (en) * | 2002-04-19 | 2004-01-08 | Stadelmann, Heinz W., Dr. | Disinfection system, especially for the disinfection of drinking and industrial water as well as the production and use of the disinfection system |
US20060075922A1 (en) * | 2004-08-26 | 2006-04-13 | Supik Albert P | Controlled-acidity composition |
-
2004
- 2004-08-20 US US10/922,604 patent/US7192618B2/en active Active - Reinstated
- 2004-08-20 CN CNA2004800428502A patent/CN101076322A/en active Pending
- 2004-08-20 WO PCT/US2004/027104 patent/WO2005091739A2/en active Application Filing
- 2004-08-20 CA CA002599345A patent/CA2599345A1/en not_active Abandoned
- 2004-08-20 EP EP04781729A patent/EP1791578A2/en not_active Withdrawn
- 2004-08-20 MX MXPA06009797A patent/MXPA06009797A/en unknown
- 2004-12-30 CN CNA200480042849XA patent/CN101188994A/en active Pending
-
2005
- 2005-02-24 US US11/065,652 patent/US20050191395A1/en not_active Abandoned
- 2005-02-25 WO PCT/US2005/006198 patent/WO2005082069A2/en active Application Filing
- 2005-02-25 MX MXPA06009800A patent/MXPA06009800A/en unknown
- 2005-02-25 CN CNA2005800130269A patent/CN101076253A/en active Pending
- 2005-02-25 CN CNA2005800130254A patent/CN101076256A/en active Pending
- 2005-02-25 CA CA002599362A patent/CA2599362A1/en not_active Abandoned
- 2005-02-25 WO PCT/US2005/006215 patent/WO2005082071A2/en active Application Filing
- 2005-02-25 EP EP05723879A patent/EP1729581A2/en not_active Withdrawn
- 2005-02-25 EP EP05723894A patent/EP1722638A4/en not_active Withdrawn
- 2005-02-25 CA CA002599366A patent/CA2599366A1/en not_active Abandoned
- 2005-02-25 MX MXPA06009798A patent/MXPA06009798A/en unknown
-
2007
- 2007-02-13 US US11/674,588 patent/US20070264398A1/en not_active Abandoned
Patent Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4346082A (en) * | 1980-01-04 | 1982-08-24 | The Vinoxen Company | Method of employing therapeutic composition comprising ammonium or substituted ammonium compounds for treatment of alcoholism |
US4338343A (en) * | 1980-06-04 | 1982-07-06 | Pennwalt Corporation | Liquid anti-microbial treatments for storage grain with ammonium bisulfite and a disproportionation product thereof |
US4500517A (en) * | 1981-12-07 | 1985-02-19 | H. B. Fuller Co. | Antimicrobial composition for a semipermeable membrane |
US4582705A (en) * | 1982-07-12 | 1986-04-15 | Leonard Primes | Composition for detoxification |
US4565689A (en) * | 1985-04-12 | 1986-01-21 | Wirth Maschinen-Und Bohrgerate-Fabrik Gmbh | Method for treating the effects of alcohol |
US4931277A (en) * | 1986-05-12 | 1990-06-05 | Michel Fontaine | Capsicum and populas useful for the treatment of alcoholic toxicomania |
US5997602A (en) * | 1995-06-22 | 1999-12-07 | Kemira Agro Oy | Aqueous fertilzer suspension containing at least phosphate ions and calcium or magnesium ions and a use of the suspension |
US5547671A (en) * | 1995-09-20 | 1996-08-20 | Duthinh; Phu | Anti-intoxication composition |
US5912030A (en) * | 1995-10-16 | 1999-06-15 | Leaf Inc. | Comestible products having extended release of addititives and method of making |
US5989595A (en) * | 1996-03-08 | 1999-11-23 | Cummins; Barry W. | Acidic composition of matter for use to destroy microorganisms |
US5968520A (en) * | 1996-11-07 | 1999-10-19 | Nam; Jong Hyun | Natural teas for taking off the effects of drink and process for the production thereof |
US6346275B1 (en) * | 1997-02-03 | 2002-02-12 | Aquacal Limited | Calcareous material |
US6514544B2 (en) * | 1998-11-19 | 2003-02-04 | Jhs-Privatstiftung | Beverage for increasing the body's capacity to break down alcohol and method thereof |
US6565893B1 (en) * | 1999-02-17 | 2003-05-20 | Worldwide Pure Water, Inc. | Process for preparing a disinfectant containing suspended metals |
US6242011B1 (en) * | 1999-08-05 | 2001-06-05 | Barry W. Cummins | Acidic composition of matter for use to destroy microorganisms |
US20020015741A1 (en) * | 2000-06-12 | 2002-02-07 | Bowen Ward Beryl | Method and composition for the accelerated in vivo removal of ethanol |
US20030012826A1 (en) * | 2001-06-29 | 2003-01-16 | Giordano John A. | Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects |
US6660293B2 (en) * | 2001-06-29 | 2003-12-09 | Everett Laboratories, Inc. | Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects |
US20040086574A1 (en) * | 2001-06-29 | 2004-05-06 | Giordano John A. | Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD569692S1 (en) | 2006-01-25 | 2008-05-27 | Jm Zell Partners, Ltd. | Wine illuminator |
USD569693S1 (en) | 2006-01-25 | 2008-05-27 | Jm Zell Partners, Ltd | Wine illuminator |
USD564303S1 (en) | 2006-09-22 | 2008-03-18 | Jm Zell Partners, Ltd | Wine illuminator |
US20080151528A1 (en) * | 2006-12-21 | 2008-06-26 | J.M. Zell Partners Ltd. | Wine Illuminator |
US20080151529A1 (en) * | 2006-12-21 | 2008-06-26 | J. M. Zell Partners Ltd. | Wine Illuminator |
US7393112B1 (en) | 2006-12-21 | 2008-07-01 | Jm Zell Partners, Ltd. | Wine illuminator |
US7407301B2 (en) | 2006-12-21 | 2008-08-05 | Jm Zell Partners, Ltd | Wine illuminator |
US20080292722A1 (en) * | 2007-05-18 | 2008-11-27 | Crudden Joseph J | Food preservation compositions and methods |
US20080299222A1 (en) * | 2007-05-18 | 2008-12-04 | Crudden Joseph J | Bioactive agrichemical compositions and use thereof |
US20080292673A1 (en) * | 2007-05-18 | 2008-11-27 | Crudden Joseph J | Bioactive agrichemical compositions and use therreof |
US20080292674A1 (en) * | 2007-05-18 | 2008-11-27 | Crudden Joseph J | Bioactive agrichemical compositions and use thereof |
WO2008144013A1 (en) * | 2007-05-18 | 2008-11-27 | Agion Technologies, Inc. | Food preservation compositions and methods |
US20080292723A1 (en) * | 2007-05-18 | 2008-11-27 | Crudden Joseph J | Bioactive acid agrichemical compositions and use thereof |
US20080292721A1 (en) * | 2007-05-18 | 2008-11-27 | Crudden Joseph J | Bioactive acid agrichemical compositrions and use thereof |
US20080292676A1 (en) * | 2007-05-18 | 2008-11-27 | Crudden Joseph J | Bioactive acid agrichemical compositions and use thereof |
US20090047364A1 (en) * | 2007-05-18 | 2009-02-19 | Crudden Joseph J | Disinfecting methods and compositions |
US8282949B2 (en) | 2007-05-18 | 2012-10-09 | Sciessent Llc | Bioactive acid agrichemical compositions and use thereof |
US8287893B2 (en) | 2007-05-18 | 2012-10-16 | Sciessent Llc | Bioactive agrichemical compositions and use thereof |
US8895044B2 (en) | 2007-05-18 | 2014-11-25 | Sciessent, Llc | Food preservation compositions and methods |
US20140072652A1 (en) * | 2010-11-09 | 2014-03-13 | Cms Innovative Technologies, Inc. | Multifunctional produce wash |
US9295254B2 (en) | 2011-12-08 | 2016-03-29 | Sciessent Llc | Nematicides |
WO2019055756A1 (en) * | 2017-09-14 | 2019-03-21 | Iti Technologies, Inc. | Anti-intoxication composition and process |
Also Published As
Publication number | Publication date |
---|---|
WO2005082069A3 (en) | 2006-10-05 |
EP1791578A2 (en) | 2007-06-06 |
CA2599362A1 (en) | 2005-09-09 |
US20070264398A1 (en) | 2007-11-15 |
US20050191394A1 (en) | 2005-09-01 |
WO2005082071A2 (en) | 2005-09-09 |
CA2599366A1 (en) | 2005-09-09 |
EP1722638A4 (en) | 2009-08-26 |
EP1729581A2 (en) | 2006-12-13 |
WO2005091739A2 (en) | 2005-10-06 |
CA2599345A1 (en) | 2005-10-06 |
CN101076256A (en) | 2007-11-21 |
WO2005091739A3 (en) | 2007-05-24 |
MXPA06009800A (en) | 2007-04-24 |
WO2005082071A3 (en) | 2006-10-26 |
EP1722638A2 (en) | 2006-11-22 |
MXPA06009797A (en) | 2007-08-14 |
WO2005082069A2 (en) | 2005-09-09 |
CN101188994A (en) | 2008-05-28 |
US7192618B2 (en) | 2007-03-20 |
CN101076253A (en) | 2007-11-21 |
MXPA06009798A (en) | 2007-08-14 |
CN101076322A (en) | 2007-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050191395A1 (en) | Hangover remedy and alcohol abatement composition | |
RU2750264C2 (en) | Synergistic composition containing aromatic substances and organic acids, and its application | |
KR100701254B1 (en) | Lactic Acid Bacteria Fermentation Solution Containing Seaweed Extract | |
WO2012124817A1 (en) | Sprouted cereal, method for manufacturing same, food product containing same, and bdnf production accelerator | |
AU775518B2 (en) | Antimicrobial lees | |
KR101371143B1 (en) | Composition comprising chlorella for improving liver function or relieving hangover | |
CN112425647A (en) | Biological fresh-keeping method for fruits | |
Olaide et al. | Use of the Lactococcus lactis IO-1 for developing a novel functional beverage from coconut water | |
CN107836507A (en) | A kind of method of prawn dominant spoilage organisms under suppression refrigerated condition | |
KR101227091B1 (en) | Food additive agents using worm-fermented liquid or worm wood-carbonized liquid | |
KR101700942B1 (en) | Sports beverage compositions | |
CN102067902A (en) | Meat product antistaling agent | |
CN115299594B (en) | Anti-fatigue sports drink and preparation method thereof | |
CN109172623A (en) | Type removing toxic substances resisting stress ecological agent used for aquiculture of splashing | |
Okarini et al. | Antioxidant Activity, Amino Acid Profile and Microbial Quality of Bebontot, a Balinese Traditional Fermented Chicken Meat Products | |
KR101693485B1 (en) | Containing a cucumber vinegar, fatigue recovery drinks and a method of manufacturing thereof | |
KR100462165B1 (en) | Additive composition for adjusting ph and preserving food and process for preparing the same | |
CN115530365B (en) | Pitaya-pineapple-dragon fruit compound enzyme and preparation method thereof | |
CN107641145B (en) | White radish seed protein extract and application thereof in preservation and freshness of aquatic products | |
KR100449909B1 (en) | Antimicrobial composition containing the calcium powder of sea urchin integument | |
KR101154864B1 (en) | Chokochujang preparation method with functionality of antimicrobial and antioxidant | |
Darsana et al. | A study on nutritional quality and identification of biogenic amine forming bacteria in marine edible species Sardinella longiceps and Loligo duvauceli from Tuticorin, Southeast coast of India | |
Ugbeni et al. | Assessment of some biochemical indices in red meat tendered with potash and extract of Ocimum basilicum | |
NAGO et al. | Manufacturing Method for Low Salt Dried Fish by Utilizing Used Tea Leaves | |
JP2024049981A (en) | Chitosan-containing brewed vinegar with reduced astringent taste, food shelf life improver, and method for improving food shelf life |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: PHARLO CITRUS TECHNOLOGIES, INC., FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CREASEY, DAVID H.;CUMMINS, BARRY W.;REEL/FRAME:016324/0946;SIGNING DATES FROM 20050221 TO 20050222 |
|
AS | Assignment |
Owner name: TASKER PRODUCTS IP HOLDINGS CORP., CONNECTICUT Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PHARLO CITRUS TECHNOLOGIES, INC.;REEL/FRAME:016882/0532 Effective date: 20051010 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |